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Abstract 
Time-dependent post-mortem biochemical changes have been demonstrated in 
donor cornea and vitreous, but there have been no published studies to date that 
objectively measure post-mortem changes in the retinal metabolome over time. The 
aim of the study was firstly, to investigate post-mortem, time-dependent changes in 
the rat retinal metabolome and secondly, to compare the metabolite composition of 
healthy rat ocular tissues. To study post-mortem changes in the rat retinal 
metabolome, globes were enucleated and stored at 4oC and sampled at 0, 2, 4, 8, 24 
and 48 hours post-mortem. To study the metabolite composition of rat ocular tissues, 
eyes were dissected immediately after culling to isolate the cornea, lens, vitreous and 
retina, prior to storing at –80oC. Tissue extracts were subjected to Gas 
Chromatograph Mass Spectrometry (GC-MS) and Ultra High Performance Liquid 
Chromatography Mass Spectrometry (UHPLC-MS). Generally, the metabolic 
composition of the retina was stable for 8 hours post-mortem when eyes were stored 
at 4oC, but showed increasing changes thereafter. However, some more rapid 
changes were observed such as increases in TCA cycle metabolites after 2 hours 
post-mortem, whereas some metabolites such as fatty acids only showed decreases 
in concentration from 24 hours. A total of 42 metabolites were identified across the 
ocular tissues by GC-MS (MSI level 1) and 2782 metabolites were annotated by 
UHPLC-MS (MSI level 2) according to MSI reporting standards.  Many of the 
metabolites detected were common to all of the tissues but some metabolites 
showed partitioning between different ocular structures with 655, 297, 93 and 13 
metabolites being uniquely detected in the retina, lens, cornea and vitreous 
respectively. Only a small percentage (1.6%) of metabolites found in the vitreous 
were exclusively found in the retina and not other tissues. In conclusion, mass 
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spectrometry-based techniques have been used for the first time to compare the 
metabolic composition of different ocular tissues. The metabolite composition of the 
retina of eyes kept at 4oC post-mortem is mostly stable for at least 8 hours. 
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INTRODUCTION 
Metabolites have many important roles in biological systems.1 The total 
complement of metabolites in a biological system is defined as the metabolome; its 
composition is both sample- and time-dependent.2, 3 As metabolites are the end 
product of biological pathways, the metabolome is a sensitive measure of disease 
phenotype and a dynamic indicator of genetic, environmental or disease-specific 
perturbations.1,4, 5  
Metabolomics is increasingly being applied as a tool in eye research. It has 
been used to characterise normal ocular tissues and biofluids including the tear film, 
lens, vitreous and retina.6-10 It has also been used to study ageing, a variety of ocular 
pathologies, metabolite transport in the retina, effects of drugs and metabolic 
changes during corneal organ culture for transplantation.11-15  
Aqueous and vitreous are the most accessible intraocular samples that can be 
obtained in clinical studies, and these have been used to interrogate the metabolic 
activities of surrounding ocular structures.11, 15 However, it is unclear whether 
sampling ocular biofluids provides robust and reproducible information on the 
metabolic activity of surrounding tissues and ideally, the metabolome of the ocular 
tissue of interest should be studied directly. One option is to use post-mortem eyes. 
However, a concern with this approach is that the concentration of metabolites can 
alter rapidly post-mortem caused by continued metabolic activity or metabolite 
instability. Time-dependent post-mortem biochemical changes have been 
demonstrated in donor cornea16 and vitreous17, but to the best of our knowledge, 
there have been no published studies to date that objectively measure post-mortem 
changes in the retinal metabolome over time.  This is important baseline information 
for future study design.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Mass spectrometry based ocular metabolomics 
 
 5 
The objectives of the study reported here were (1) to investigate post-mortem 
changes in the rat retinal metabolome over 48 hours when eyes are stored at 4oC 
(temperature at which human post-mortem eyes are stored in real-life) and (2) for the 
first time, annotate and characterise the metabolic composition of four ocular tissues 
(cornea, lens, vitreous and retina).  
 
METHODS 
Animals 
All animal experiments were conducted in accordance with the United 
Kingdom (UK) Home Office regulations for the care and use of laboratory animals, 
the UK Animals (Scientific Procedures) Act (1986), and the ARVO Statement for the 
Use of Animals in Ophthalmic and Vision Research. Twenty-one, male, Sprague 
Dawley rats were included in the post-mortem study (42 eyes in total) and six rats 
were included in the tissue comparison study; all rats were in the age-range of 7-12 
weeks. The rats were kept in the same room under standard laboratory conditions 
and fed with standard chow. The rats were culled by carbon dioxide inhalation 
followed by cervical extension; this process was staggered to ensure rapid sample 
collection. Enucleation was performed as soon as possible (between 1 to 20 minutes) 
after death.  If eyes were not dissected immediately (T=0 hour samples), they were 
placed in small bottles and stored on ice before transferring to a refrigerator and then 
stored in the dark for up to 48 hours at 4°C  (T=2-48 hour samples).  
 
Dissection 
Seven eyes were studied at each time point for the retinal metabolic stability 
study and six eyes were studied to annotate and characterise the metabolome of 
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different ocular tissues. Dissections of the rat eyes at T=0 were performed 
immediately after culling and the stored eyes were dissected at 2, 4, 8, 12, 24 and 48 
hours post culling to remove the retina. Under microscope guidance the cornea was 
carefully removed.  Then the iris was divided with forceps and the lens removed in 
one piece to gain access to the posterior segment. Vitreous was meticulously 
separated from the retina. Lastly, the neurosensory retina was removed avoiding 
contamination with the retinal pigment epithelium/Bruch’s membrane/choroid 
complex. All dissections were performed on a cold plate to maintain a temperature of 
approximately 4oC and dissection time was between 2 to 5 minutes. The dissected 
tissues were snap-frozen with liquid nitrogen and then stored at -80oC before 
extraction.  
 
Sample preparation 
Each tissue sample was carefully weighed prior to extraction, mean weights 
were as follows; retina 25.4mg; vitreous 30.1mg; lens 32.7mg; cornea 7.9mg. 
Metabolite extraction was achieved by adding 800µL of chloroform:methanol (50:50, 
pre-cooled to -20oC) followed by 50µL of an internal standard mixture (0.1 mg/ml d5 
Benzoic acid, d4 Succinic acid and d5 Glycine dissolved in methanol) to each pre-
weighed sample. Homogenisation/extraction was performed in a TissueLyser 
(Qiagen; 25Hz, 10 minutes using one 3mm tungsten carbide bead). Next, 400µL of 
water was added and the mixture was vortexed and allowed to stand on ice for 10 
minutes. The samples were then centrifuged (5 minutes, 13,000g) to allow separation 
of the solvents. The top hydrophilic layer (to be analysed by GC-MS) and bottom 
lipophilic layer (to be used for UHPLC-MS analysis) were transferred into separate 
tubes and dried (Savant SPD131DDA with an RVT4104 cold trap, Thermo Scientific). 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Mass spectrometry based ocular metabolomics 
 
 7 
The volume of polar and non-polar extractions collected was normalised to the lowest 
tissue weight for each tissue type in each study. Quality control (QC) samples were 
prepared by pooling together an aliquot of 100µL from each retina sample after 
extraction and before drying. The QC samples were used for quality assurance as 
described by Dunn et al.18  
 
UHPLC-MS analysis 
All tissue extract samples and QC samples were reconstituted in 200µL 50:50 
water:methanol prior to analysis. The samples were analysed using an Accela Ultra 
High Performance Liquid Chromatography system coupled to an electrospray hybrid 
LTQ-Orbitrap Velos mass spectrometer (ThermoFisher Scientific, Bremen, 
Germany). All samples were analysed separately in positive and negative ion modes. 
QC samples were analysed for the first ten injections and then every fifth injection. 
The last two injections were also QC samples. Chromatographic separations were 
performed, following injection of a 10µL sample volume, onto a Hypersil GOLD 
column (100x2.1mm, 1.9µm; ThermoFisher Scientific, Runcorn, UK) with the column 
temperature set at 50°C. The two solvents applied w ere solvent A -0.1% formic acid 
in water (vol/vol) and solvent B -0.1% formic acid in methanol (vol/vol)) at a flow rate 
of 400µL/min. Solvent A was held at 100% for 0.5 minutes followed by an increase to 
100% solvent B over 4.5 minutes, which was then held at 100% solvent B for a 
further 5.5 minutes. At 10.5 minutes, it was changed to 100% solvent A and held at 
100% solvent A to equilibrate for 1.5 minutes. All column eluent was transferred to 
the mass spectrometer. Full-scan profiling data were acquired in an Orbitrap mass 
analyser (mass resolution 30,000 at m/z =400). 
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Raw data files (.RAW format) generated from the UHPLC-MS system were converted 
to the NetCDF format using the File converter program in the XCalibur software 
package (ThemoFisher Scientific, Bremen, Germany). Deconvolution was performed 
using XCMS software19 as described previously.20 Whilst relative concentrations 
were measured no absolute quantification of metabolites to define concentrations per 
gram of tissue was performed. For quality assurance, only metabolite features 
detected in greater than 60% of QC samples and with a response not deviating 
greater than 20% from the QC mean were retained for further data analysis. All data 
was normalised to total peak area for each sample18. Annotation of the metabolite 
features detected in the UHPLC-MS system was performed by applying the 
PUTMEDID-LCMS set of workflows, as described previously.21 A retention time 
window of 3s and a mass error of +/-5ppm was applied with a correlation coefficient 
of 0.75. Using this technique metabolites were putatively annotated (class 2 
annotations) applying mass-to-charge ratio or mass-to-charge ratio and match to 
MS/MS spectra available in external mass spectral libraries (METLIN, MassBank and 
mzCloud)  according to the Metabolomics Standards Initiative recommendations.22  
 
GC-MS analysis 
All samples were chemically derivatised prior to analysis. 60µL of a 
20mg/mL methoxylamine hydrochloride in dry pyridine solution was added to each 
sample. The samples were vortex mixed for 10s and heated for 20 minutes at 80°C. 
60µL of N-methyl-N-trimethylsilyl-trifluoroacetamide was added and the samples 
were heated at 80°C for 20 minutes. After cooling, 20µL of a retention marker 
solution (n-alkanes C10, C12, C15, C19, C22, C26, C28, C30, C32, 3mg/mL in dry pyridine) 
was added to each solution. The samples were vortex-mixed and centrifuged (15 
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minutes, 13,000g). 96µL of supernatant from each sample was transferred to GC 
vials for analysis.  
All samples were analysed using an Agilent 7890 Gas Chromatograph (Agilent 
technologies, Stockport, UK) coupled with a LECO Pegasus HT TOF mass 
spectrometer (Leco, Stockport, UK). QC samples were analysed for the first five 
injections and then every fifth injection. The last two injections were also QC 
samples. 1µL pulsed splitless injections were made at 270oC with a Gerstel MPS2 
autosampler, using a 30s pressure pulse and purge time, and a ‘hot, empty needle’ 
technique, onto a 30mx0.25mmx0.25µm RXi-17 column (Restek) coupled to a 
2mx0.25mm intermediate polarity retention gap (Restek), through an Agilent 
Split/Splitless injector equipped with a 4mm splitless liner. Helium carrier gas was set 
at a 1.4 mL/min constant flow; oven temperature programme was held at 50oC for 4 
minutes, then a linear temperature ramp from 50-150oC at 20oC/min, followed by a 
linear temperature ramp of 150-300oC at 15oC/min with a hold temperature of 
300oC for 4 minutes. The column was led directly into the ion source (220oC) of the 
mass spectrometer via a transfer line held at 240oC. Data were acquired at 20Hz, 
over the m/z range 45-600Da, with a 420s solvent delay prior to acquisition.  
Raw instrument data were pre-processed applying the ChromaTof software (LECO; 
v4.22) using a previously described method and its associated chromatographic de-
convolution algorithm, with the baseline set at 1.0, data point averaging of 3 and 
average peak width of 2.5.18 The peak area was reported and the response ratio 
relative to the internal standard (peak area-metabolite/peak area-succinic-d4 acid 
internal standard) was calculated. Whilst relative concentrations were measured no 
absolute quantification of metabolites to define concentrations per gram of tissue was 
performed. These data representing normalised peak lists were exported in .txt 
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format. Most metabolites were definitively identified (MSI level 1), but a small number 
were putatively annotated (MSI level 2 or 3) according to The Metabolomics 
Standards Initiative reporting standards22 by comparison of retention index and mass 
spectra acquired from the samples with those present in mass spectral libraries 
(NIST08, Golm Metabolome Database and Manchester Metabolomics Database).21 
Processed data were directly exported to Microsoft Excel® (.xls) worksheets for 
further data analysis. 
 
Statistical analysis of retina stability 
All statistical analyses were carried out using MetaboAnalyst.23 All data were 
normalised to total peak area for each sample. Log2 transformation was applied for 
univariate analysis to enhance a normal distribution in the datasets. KNN missing 
value imputation and Pareto scaling was applied for multivariate analysis only. 
Metabolite features with greater than 50% missing values for the retinal stability study 
were removed prior to analysis. Univariate analysis applying one-way ANOVA and 
multivariate analysis (applying Principal Components Analysis (PCA)) were applied 
to data acquired from both studies. False discovery rate (FDR) was calculated 
applying the Benjamini–Hochberg procedure,24 q<0.05 was used to determine the 
statistical significance. FDR applies a statistical approach to correct for multiple 
testing in large datasets and to control the expected number of false positives.  
 
Comparison of the metabolome of different ocular tissues 
Six biological replicates for each tissue type were analysed by applying GC-
MS and UHPLC-MS and the metabolites were putatively annotated or identified as 
described above. For putatively annotated metabolites reported more than once (as 
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multiple metabolite features with the same retention time but different mass-to-
charge ratios) the entry with the highest total peak area sum across all four tissue 
types was retained while all other duplicates were deleted. Applying this dataset of 
unique metabolite annotations, the number of metabolites observed in each 
combination of tissue type was calculated. 
 
Results 
1. Post-mortem change in the rat retina metabolome 
All data analysis used relative peak areas. The absolute concentrations for all 
metabolites were not determined as this is not technically feasible for the thousands 
of metabolites detected in non-targeted metabolomics studies where the metabolome 
composition is not known prior to data acquisition, as many metabolites are not 
available to prepare calibration solutions.  
Unsupervised multivariate PCA analysis scores plots of the GC-MS data 
(Figure 1) and the UHPLC-MS data (Figure 2) showed no separation of retinal 
samples for eyes stored for 0, 2, 4 and 8 hours, whereas samples stored for 24 and 
48 hours were clearly separated. These results imply that samples stored at 4°C are 
largely metabolically stable for the first 8hrs, but that multiple changes in the 
metabolic composition commence after that.  
Univariate one-way ANOVA was applied to identify those metabolite features 
that demonstrated a statistically significant difference in relative concentrations 
between these time points. 16 identified and 133 annotated metabolite features were 
statistically significant (q<0.05) for GC-MS and UHPLC-MS, respectively. Analysis of 
the GC-MS data revealed increases in the concentration of two metabolites present 
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in the TCA cycle from 2 hours post mortem (namely citrate and malate), increases in 
six and a decrease in one amino acid from 8 hours post mortem and decreased 
levels of five fatty acids from 24 hours post mortem. (Table 1) More detailed 
information on these data is available in Supplementary Information 1. Analysis of 
metabolites detected by UHPLC-MS showed that 10 classes of metabolites 
underwent statistically significant (q<0.05) changes post mortem including acyl 
carnitines (10), diacylglycerides (12), aromatic amino acids (3), bile acids (7), 
ceramides and sphingolipids (9), fatty acids/fatty alcohols/fatty amides (16), 
glycerophospholipids (33), lysoglycerophospholipids (18), steroid hormones (5) and 
vitamin D metabolites (7). These data are available in Supplementary Information 2. 
As observed for GC-MS, different metabolites and metabolite classes showed 
different periods of stability. For example, acyl carnitines showed a change in 
concentration from as early as two hours, bile acids from 4 hours and aromatic amino 
acids from 24 hours. Some classes showed that metabolites within each class 
showed different levels of stability. Box and whisker plots for 4 exemplar metabolites 
are shown in Figure 3. 
 
2. Characterisation of rat cornea, lens, vitreous and retina metabolome 
2.1 GC-MS 
A total of 42 unique metabolites were identified according to MSI reporting 
level 1 (i.e. identified metabolites). 20 were detected in the cornea, 32 in the lens, 19 
in the vitreous and 21 in the retina. 1, 13, 2 and 3 unique metabolites were detected 
only in the cornea, lens, vitreous or retina, respectively. The metabolites may have 
been present at concentrations lower than the detection limits of the analytical 
methods applied and therefore this method qualitatively defines differences in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Mass spectrometry based ocular metabolomics 
 
 13
concentrations and not necessarily the presence or absence of a metabolite at any 
concentration. (See Table 2 for the list of metabolites detected in the tissues.) 
 
2.2 UHPLC-MS 
There were a total of 2782 unique metabolites detected in one or more tissue 
(cornea, lens, vitreous and retina). The majority of metabolites are annotated 
according to MSI level 2 (i.e. putatively annotated compounds). Many of these were 
detected in all or most of the tissues with 443 metabolites being common to all 
tissues. 93, 297, 13 and 655 metabolites were found only in cornea, lens, vitreous 
and retina respectively. Only 13 of 1261 (1%) metabolites detected in vitreous were 
unique to vitreous, whereas 655 of 1942 (34%) of metabolites detected in retina were 
unique to retina. 1.6% of metabolites found in the vitreous were uniquely found in the 
retina and not other tissues. The list of metabolites detected in the tissues studied 
can be found in Supplementary Information 3. The Venn diagram in Figure 4 
illustrates the distribution of these metabolites across the four tissues. As can be 
seen a large list of putatively annotated metabolites were detected in one or more 
tissue. The aim of this study was not to provide a list of all metabolites in each tissue 
but rather to provide an overview of the similarities and differences in the 
metabolomes across the four different ocular tissues. Many different classes of 
metabolites were detected including acyl carnitines, acyl glycerides, amino acids, 
ceramides and sphingolipids, fatty acids, fatty amides, glycerophospholipids, 
lysoglycerophospholipids, iodo- and fluoro-metabolites, nucleosides/nucleotides, 
oxidative phosphorylation, steroid hormones and vitamin D metabolites. 
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Discussion 
Two complementary MS techniques where used in this study: GC-MS that 
detects small polar metabolites, and UHPLC-MS that detects non-polar metabolites, 
specifically lipids.  The analysis of post-mortem changes in the rat eye was 
undertaken to establish protocols for the metabolomic analysis of eye tissue from 
animal models and to explore whether it may be feasible to use human ocular tissue 
for metabolic studies and if so how quickly it would need to be processed. Univariate 
and multivariate analysis of data acquired applying GC-MS and UHPLC-MS 
demonstrated that the metabolic composition of the rat retina remained largely stable 
for the first 8 hours post-mortem when maintained at 4oC, but thereafter an 
increasing proportion of metabolites changed in relative concentration. A small 
number of metabolites showed changes in their concentration from 2 hours, including 
two metabolites present in the TCA cycle. These metabolites (citrate and malate) 
increased in concentration, suggesting a reduction in their catabolism and/or an 
increase in their synthesis. Citrate and malate can be both the substrates and 
products of the TCA cycle. The TCA cycle consists of sequential reversible, and 
irreversible chemical reactions, in which its directionality depends on the state of 
oxygen in the tissue.25 In anaerobic conditions, oxaloacetate can be converted into 
malate and this may explain the increased in concentration in our post-mortem 
retina.26, 27 In fact, malate has been found to increase 4-fold in cardiac ischaemia.28 
Citrate is used as a substrate only in aerobic conditions towards the synthesis of 
alpha-ketaglutarate. In anaerobic conditions, backflux may occur and citrate 
accumulates as a product of the cycle.29, 30 If the theory of increase in synthesis were 
true to account for the increased concentration of these 2 metabolites, it suggests 
that TCA cycle continues in anaerobic condition over 48 hours in the rat retina when 
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stored at 4OC. An earlier study showed that post-mortem retinas can retain their 
metabolic capacities for 4- 4 1/2 hours following death and this capacity is increased 
when the tissue is kept at 4oC31  but to the best of our knowledge, there are no 
studies that look at the TCA cycle in post-mortem rat retina. However, it is also likely 
the increased in concentration of citrate and malate is a result of reduced TCA cycle 
and hence, reduced consumption of the metabolites. Other metabolites such as the 
amino acids (leucine, methionine, phenylalanine, tryptophan) were largely stable in 
the first 24 hours post-mortem but followed an increasing trend over the 48hrs time 
period. Many of the neurotransmitters required for normal retinal cell function occur 
as free amino acids in the retina. Most of them are generated from the intermediates 
in the TCA cycle32 , suggesting that the TCA cycle is on-going during this period but 
consumption of the metabolites by the retinal cells may be reduced due to an overall 
decrease in metabolic activity in hypoxic conditions, hence the increased in its 
concentration. Further studies are required to investigate other metabolites involved 
in the TCA cycle under different temperatures.  
 
The level of glutamate, on the other hand, falls over post-mortem time. 
Glutamate is an excitatory neurotransmitter in the brain and retina. Studies have 
shown an increased extracellular level of glutamate in cerebral ischaemia.33, 34 An 
elevated glutamate level was also found in the vitreous of eyes with glaucoma, 
thought to be indicative of retinal ganglion cell death.35 It is uncertain why the 
glutamate level in our study decreases over post-mortem time where severe hypoxia 
can be assumed. It may be that the equilibrium favours the synthesis of alpha-
ketaglutarate from glutamate in the TCA cycle in the state of hypoxia when the 
temperature is low.    
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Uracil, a nucleobase in the nucleic acid of RNA was also found increase in 
concentration. Similar trend was observed in post-mortem porcine vitreous humour.36 
Ascorbic acid and some of the fatty acids decreased in concentration over time. This 
is most likely due to an overall reduced synthesis and increased consumption. 
Ascorbic acid is an antioxidant and it is unsurprising that the level plummets in 
hypoxic conditions. It should be noted that samples were collected within 20 minutes 
of death and that a small level of metabolic activity could remain present during this 
time. This implies that the T=0 samples are potentially not identical to the 
metabolome at death; however, the authors believe that these changes will be small 
compared to the metabolic changes observed at later time points. Based upon these 
experiments we conclude that post-mortem human tissue would need stabilisation 
within 8 hours following enucleation and storage at 4OC to be used for metabolomics 
studies and that tissue retrieved following surgery could be used if appropriate 
protocols are in place to quickly stabilise it for metabolomics studies.  
 
A large number of metabolites were identified (to MSI level 1) or annotated (to 
MSI level 2) in the cornea, lens, vitreous and retina using MS-based techniques; 42 
and 2782 for GC-MS and UHPLC-MS respectively. We decided to analyse the water-
soluble metabolites applying GC-MS though the application of UHPLC-MS applying a 
HILIC column would allow a greater number of water-soluble metabolites to be 
detected. The data acquired show that some identified/annotated metabolites were 
uniquely detected in only one tissue, whereas many others were detected in two or 
more tissues. The retina displayed the most unique profile of identified/annotated 
metabolites with 655 detected only in this tissue. The cornea and vitreous contained 
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fewer unique identified/annotated metabolites. Interestingly, only a small percentage 
(1.6%) of identified/annotated metabolites found in the vitreous were exclusively 
found in the retina and not other tissues. Vitreous is composed of approximately 98% 
water, 1% macromolecules including collagen, hyaluronan and soluble protein and 
low molecular weight molecules including metabolites that are derived from adjacent 
ocular tissues and blood plasma.37 There is metabolic exchange between the cornea 
and aqueous, and the lens with vitreous and aqueous; so the movement of 
metabolites between these compartments may explain the similarities between the 
metabolites found in the lens, vitreous and cornea. However, there is a bulk flow of 
water posteriorly from the vitreous through the retina38 and this uni-directional 
anterior to posterior flow may inhibit the anterior movement of small molecules from 
the retina into the vitreous resulting in the vitreous metabolome not reflecting that of 
the retina. Vitreous has been used as the surrogate for analysing molecular changes 
taking place in the retina, but this study suggests that metabolic footprinting of 
vitreous may not always be informative with respect to metabolic activity in the retina.  
However, in some pathological states where there is increased permeability of the 
retinal vessels or RPE, vitreous analysis may be of value. This study provides a 
guide to the classes of common metabolites that can be expected either exclusively 
or non-exclusively across different ocular tissues and serve as valuable baseline 
knowledge to future studies. For example, one of the common metabolites detected 
in both the retina and vitreous only in our study was urate. Baban et al39 found an 
increased in purine metabolism in the diabetic retina that corresponded to an 
increased vitreal urate level. We also know from our study that urate can be detected 
in the vitreous.  Hence, studies looking at vitreal urate level will always need to 
include a control group to measure differences in concentration. On the other hand, 
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we know that vitreous sample would not be a good surrogate in studies looking at 
certain metabolites that were found exclusively identified in the retina (ie. Retinal 
palmitate, an antioxidant), in physiological states at least.  
  
In conclusion, applying metabolomics to ocular tissues is likely to become an 
increasingly important technique for studying diseases of the eye, identifying 
biomarkers and investigating the effects of therapeutic interventions.  However, 
caution must be applied when assuming that sampling of ocular biofluids will give 
insights into the metabolome of adjacent tissue structures.  When analysing the 
metabolome of ocular tissue post-mortem, it is important to recognise that there are 
time-dependent post-mortem changes, which will make it challenging to use human 
tissue, although if stringent methodologies are applied, metabolomics could be a very 
valuable approach in animal models.  
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Table 1: List of metabolite features identified by GC-MS that have changed 
significantly over 48 hours post-mortem period and its direction of change, indicated 
by median of its relative concentration at 0 hour over 48 hours.  
 
Table 2: List of metabolites detected across different ocular tissues using the GC-
MS. 
 
 
Figure 1. PCA scores plot for data acquired for the retina by GC-MS showing partial 
or complete separation of samples collected 8, 24 and 48 hours post-mortem after 
storage at 4oC. Red circle = retina extracted after 0 hours storage; green circle = 
retina extracted after 2 hours storage; dark blue circle = retina extracted after 4 hours 
storage; cyan circle = 
retina extracted after 8 hours storage; pink circle = retina extracted after 24 hours 
storage; yellow circle = retina extracted after 48 hours storage; grey circle = quality 
control sample (QC).  
 
Figure 2. PCA scores plot for data acquired for the retina applying (a) positive ion 
UHPLC-MS and (b) negative ion UHPLC-MS showing partial or complete separation 
of samples collected 8, 24 and 48 hours post-mortem after storage at 4oC. Red circle 
= retina extracted after 0 hours storage; green circle = retina extracted after 2 hours 
storage; dark blue circle = retina extracted after 4 hours storage; cyan circle =retina 
extracted after 8 hours storage; pink circle = retina extracted after 24 hours storage; 
yellow circle = retina extracted after 48 hours storage; grey circle = quality control 
sample (QC).  
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Figure 3. Box and whisker plots showing changes in metabolite concentrations over 
a 48 h period for (a) malic acid, (b) ascorbic acid, (c) octadecatrienoic carnitine and 
(d) PC(40:4) 
 
Figure 4. Venn diagram showing the number of unique metabolite detected across 
different ocular tissues (cornea, vitreous, retina, lens) by (a) GC-MS and (b) UHPLC-
MS 
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Table 1: List of metabolite features identified by GC-MS that have changed 
significantly over 48 hours post-mortem period and its direction of change, 
indicated by median of its relative concentration at 0 hour over 48 hours.  
 
Metabolite 
Time point where statistically 
significant changes in concentration 
were first observed  (hours) 
Median(0 hours) 
/Median(48 hours) 
Leucine 48 0.452 
Glycerol 24 2.453 
Uracil 24 0.128 
Malic acid 2 0.243 
Methionine 24 0.236 
Creatinine 2 1.551 
Glutamic acid 8 1.352 
Phenylalanine 24 0.283 
Citric acid 2 0.404 
Tetradecanoic acid 24 1.822 
Ascorbic acid 48 7.900 
Hexadecanoic acid 8 1.609 
Heptadecanoic acid 24 2.319 
Stearic acid 24 1.740 
Tryptophan 48 0.089 
Arachidic Acid 24 1.592 
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Table 2: List of metabolites detected across different ocular tissues using the GC-
MS. 
Metabolite Sample type in which metabolite was detected 
Arachidic Acid Cornea 
4-hydroxyproline Lens 
Adenosine-5-monophosphate Lens 
Cysteine Lens 
glycerol-3-phosphate Lens 
Leucine Lens 
Mannitol Lens 
N-formylmethionine Lens 
Pentanedioic acid, 2-hydroxy Lens 
Ribitol Lens 
Scyllo-inositol Lens 
Threitol Lens 
Tolnaftate Lens 
Valine Lens 
Butanoic acid Retina 
Citric acid Retina 
Serine Retina 
4-aminobutyric acid Vitreous 
Benzoic acid  Vitreous 
1-Iodo-2-methylundecane Cornea and vitreous 
Glucose Cornea and vitreous 
glycerol Lens and cornea 
Tyrosine Lens and retina 
5,5-dithiobis-(2-nitrobenzoic 
acid) Lens and vitreous 
Threonic acid Lens and vitreous 
Tetradecanoic acid Vitreous and retina 
Creatinine Cornea, retina and vitreous 
Aspartic acid Lens, cornea and retina 
Glycine Lens, cornea and retina 
Phenylalanine Lens, cornea and retina 
Propanoic acid, 2-hydroxy Lens, cornea and retina 
Butane, 1,4-dibromo- Lens, cornea, vitreous and retina 
Butanedioic acid Lens, cornea, vitreous and retina 
Hexadecanoic acid Lens, cornea, vitreous and retina 
Lactic acid Lens, cornea, vitreous and retina 
Malic acid Lens, cornea, vitreous and retina 
myo-Inositol Lens, cornea, vitreous and retina 
phosphate Lens, cornea, vitreous and retina 
Pyroglutamic acid Lens, cornea, vitreous and retina 
Stearic acid Lens, cornea, vitreous and retina 
Threonine Lens, cornea, vitreous and retina 
Urea Lens, cornea, vitreous and retina 
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Figure 1. PCA scores plot for data acquired for the retina by GC-MS showing partial 
or complete separation of samples collected 8, 24 and 48 hours post-mortem after 
storage at 4oC. Red circle = retina extracted after 0 hours storage; green circle = 
retina extracted after 2 hours storage; dark blue circle = retina extracted after 4 hours 
storage; cyan circle = 
retina extracted after 8 hours storage; pink circle = retina extracted after 24 hours 
storage; yellow circle = retina extracted after 48 hours storage; grey circle = quality 
control sample (QC).  
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Figure 2. PCA scores plot for data acquired for the retina applying (a) positive 
ion UHPLC-MS and (b) negative ion UHPLC-MS showing partial or complete 
separation of samples collected 8, 24 and 48 hours post-mortem after storage 
at 4oC. Red circle = retina extracted after 0 hours storage; green circle = 
retina extracted after 2 hours storage; dark blue circle = retina extracted after 
4 hours storage; cyan circle =retina extracted after 8 hours storage; pink circle 
= retina extracted after 24 hours storage; yellow circle = retina extracted after 
48 hours storage; grey circle = quality control sample (QC).  
(a) 
 (b) 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Figure 3. Box and whisker plots showing changes in metabolite 
concentrations over a 48 h period for (a) malic acid, (b) ascorbic acid, (c) 
octadecatrienoic carnitine and (d) phosphatidylcholine (40:4) 
 
 
(a) 
 
 
 
(b) 
 
 
(c) 
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(d) 
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Figure 4. Venn diagram showing the number of unique metabolite detected across 
different ocular tissues (cornea, vitreous, retina, lens) by (a) GC-MS and (b) UHPLC-
MS 
 
(a) 
 
 
(b) 
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Highlights 
 
 
• Many metabolites were detected across the vitreous, retina, lens and 
cornea using mass spectrometry-based technique. 
 
• The retina displayed the most unique profile of metabolites with a large 
number of metabolites detected only in this tissue. The cornea and 
vitreous contained fewer unique metabolites.  
 
• Only a small percentage (1.6%) of metabolites found in the vitreous 
were exclusively found in the retina and not other tissues. 
 
• The metabolite composition of the retina of eyes kept at 4oC post-
mortem is mostly stable for at least 8 hours. 
 
 
